NCT06015724
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06015724
Title Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer (DARANIVOVAX)
Acronym DARANIVOVAX
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown Lombardi Comprehensive Cancer Center RECRUITING Washington D.C. District of Columbia 20007 United States Details
John Theurer Cancer Center at Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field